Femoston 1/10

Femoston 1/10: Anti-climacteric drug from the Netherlands

Femoston 1/10 is a drug that belongs to the group of antimenopausal drugs. It is produced by the Dutch pharmaceutical company Solvay Pharma. The main active ingredients in the drug are estradiol and dydrogesterone.

Femoston 1/10 is available in the form of film-coated tablets. The drug is used in hormone replacement therapy to treat disorders caused by estrogen deficiency in postmenopausal women. It can also be used to prevent postmenopausal osteoporosis.

Before using Femoston 1/10, contraindications must be taken into account. The drug is not recommended in case of hypersensitivity to its components, presence of diagnosed or suspected breast cancer, endometrial cancer or other hormone-dependent neoplasms. It should also not be used in the presence of vaginal bleeding of unknown etiology, confirmed acute deep vein thrombosis or pulmonary embolism, as well as cerebrovascular accidents.

The use of Femoston 1/10 may be accompanied by some side effects. From the genitourinary system, acyclic menstrual-like spotting bleeding from the vagina may occur. From the gastrointestinal tract, nausea, vomiting, flatulence, abdominal pain and cholestatic jaundice may be observed. Allergic reactions such as erythema nodosum, rash and itching are also possible. Other side effects may include headache, migraine, dizziness, depression, chorea minor, breast tenderness, chloasma or melasma, contact lens intolerance, hypertension, thrombosis, peripheral edema, weight changes, changes in libido, and muscle cramps. lower extremities.

You must be careful about the interaction of Femoston 1/10 with other drugs. Drugs that are inducers of microsomal liver enzymes, such as barbiturates, phenytoin, rifampicin and carbamazepine, can weaken the estrogenic effect of Femoston 1/10.

In case of an overdose of Femoston 1/10, side effects may increase